Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction

Abstract

Paracrine-acting proteins are emerging as a central mechanism by which bone marrow cell-based therapies improve tissue repair and heart function after myocardial infarction (MI). We carried out a bioinformatic secretome analysis in bone marrow cells from patients with acute MI to identify novel secreted proteins with therapeutic potential. Functional screens revealed a secreted protein encoded by an open reading frame on chromosome 19 (C19orf10) that promotes cardiac myocyte survival and angiogenesis. We show that bone marrow-derived monocytes and macrophages produce this protein endogenously to protect and repair the heart after MI, and we named it myeloid-derived growth factor (MYDGF). Whereas Mydgf-deficient mice develop larger infarct scars and more severe contractile dysfunction compared to wild-type mice, treatment with recombinant Mydgf reduces scar size and contractile dysfunction after MI. This study is the first to assign a biological function to MYDGF, and it may serve as a prototypical example for the development of protein-based therapies for ischemic tissue repair.

Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles

“…41 Successful acute IR injury was confirmed not only by visual inspection of left ventricle (LV) color alteration but also by ST-segment-characterized electrocardiogram.…”

Tracking stem cells with superparamagnetic iron oxide nanoparticles: perspectives and considerations

“…105,106 Similar to other striated muscles, the injured cell milieu generated by the damage dictates the tropism of resident progenitor and stem cells to the injury site, mediating a certain degree of self-recovery, [103][104][105][106][107] but since the adult cardiomyocytes are known to be in mitotic arrest, this limits the repair mechanism. 108,109 Thus, considering the low regeneration potential of the endogenous mechanisms attempts to stimulate regeneration by using exogenous stem cells seem plausible.…”

Emerging roles for macrophages in cardiac injury: cytoprotection, repair, and regeneration

“…First, CDC-modulated macrophages may secrete factors with antiapoptotic actions. A recent study identified infarct monocytes and macrophages as an important source of myeloid-derived growth factor (MYDGF), a secreted protein that promotes cardiomyocyte survival (13 The mammalian heart contains a population of resident macrophages that expands in response to myocardial infarction through the recruitment of monocytes. Infarct macrophages exhibit high phenotypic diversity and respond to microenvironmental cues by altering their functional properties and secretory profile.…”